BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nowaczyk A, Szwedowski D, Dallo I, Nowaczyk J. Overview of First-Line and Second-Line Pharmacotherapies for Osteoarthritis with Special Focus on Intra-Articular Treatment. Int J Mol Sci 2022;23:1566. [PMID: 35163488 DOI: 10.3390/ijms23031566] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Li H, Wang Q, Gong D. LINC00313 alleviates osteoarthritis progression in mice through promoting TRAF1 promoter methylation and inhibiting the ASK1/JNK signaling pathway. Immunopharmacol Immunotoxicol 2022;:1-14. [PMID: 35815528 DOI: 10.1080/08923973.2022.2078728] [Reference Citation Analysis]
2 Zewail MB, F Asaad G, Swellam SM, Abd-Allah SM, K Hosny S, Sallah SK, E Eissa J, S Mohamed S, El-Dakroury WA. Design, characterization and in vivo performance of solid lipid nanoparticles (SLNs)-loaded mucoadhesive buccal tablets for efficient delivery of Lornoxicam in experimental inflammation. Int J Pharm 2022;624:122006. [PMID: 35820515 DOI: 10.1016/j.ijpharm.2022.122006] [Reference Citation Analysis]
3 Lim YY, Miskon A, Zaidi AMA. Structural Strength Analyses for Low Brass Filler Biomaterial with Anti-Trauma Effects in Articular Cartilage Scaffold Design. Materials 2022;15:4446. [DOI: 10.3390/ma15134446] [Reference Citation Analysis]
4 Valentino A, Conte R, De Luca I, Di Cristo F, Peluso G, Bosetti M, Calarco A. Thermo-Responsive Gel Containing Hydroxytyrosol-Chitosan Nanoparticles (Hyt@tgel) Counteracts the Increase of Osteoarthritis Biomarkers in Human Chondrocytes. Antioxidants (Basel) 2022;11:1210. [PMID: 35740107 DOI: 10.3390/antiox11061210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]